期刊文献+

季也蒙念珠菌感染临床分析 被引量:1

Clinical Analysis of Candida Guilliermondii Infection
原文传递
导出
摘要 目的对季也蒙念珠菌感染患者的临床及微生物学特征进行分析,为临床诊治提供参考。方法收集2006年1月2008年12月病原菌培养为季也蒙念珠菌的10例住院患者资料进行回顾性分析。结果季也蒙念珠菌感染患者存在多种基础疾病,大多数患者(8/10)有易感因素,其中7例使用广谱抗菌药物。10例中有8例为深部真菌感染。其临床表现与感染部位有关,主要累及泌尿道、呼吸道和皮肤软组织。多数深部感染患者(6/8)在感染前存在同部位细菌感染,部分患者(3/8)在相同部位还可分离出其他真菌。全部季也蒙念珠菌菌株对两性霉素B敏感,大多数菌株(9/10)对氟康唑敏感。仅1例患者因肺部感染、呼吸衰竭死亡,其余患者经氟康唑、伊曲康唑或特比萘芬等抗真菌药物治愈。结论季也蒙念珠菌感染多发生于有基础疾病、存在真菌易感因素者,感染部位多为原细菌感染部位,常合并其他细菌或真菌感染。部分菌株对氟康唑和伊曲康唑中敏或耐药,治疗应根据药敏进行选择。 Objective To analyze the clinical and microbiologic characters of candida guilliermondii to improve the clinical diagnosis and treatment.Methods The clinical data of 10 patients with candida guilliermondii infection diagnosed in our hospital from January 2006 to December 2008 were retrospectively analyzed.Results All the patients had several underlying conditions;eight patients had predisposing factors and seven patients were prescribed with broad-spectrum antibacterials.Eight patients had deep mycoses,whose clinical manifestation was associated with the infectious sites,mainly involved in urinary tract,respiratory tract and skin-soft tissues.Most deep mycoses(6/8) had prior bacterial infection at the candida guilliermondii infection site;some patients(3/8) had other fungous infection at the same time.All the strains were sensitive to amphotericin B;most fungous strains(9/10) were sensitive to fluconazole.One patient died of pulmonary infection and respiratory failure,and the others were cured by fluconazole,itraconazole or terbinafine.Conclusion Candida guilliermondii infection mainly occurs in patients with underlying conditions and predisposing factors.The infectious sites have prior bacterial infection and bacterial infection or fungous infection at the same time.Since some candida guilliermondii strains were not sensitive to fluconazole and itraconzole,drug sensitive test should be consulted
出处 《华西医学》 CAS 2011年第1期34-37,共4页 West China Medical Journal
关键词 季也蒙念珠菌 病原菌 真菌病 Candida guilliermondii Pathogenic bacteria Fungous disease
  • 相关文献

参考文献22

  • 1Maschmeyer G. The changing epidemiology of invasive fungal infections: new threats[J]. Int J Antimicroh Agents, 2006,27 (Suppl 1) :3-6.
  • 2Chakrabarti A, Chatterjee SS, Rao KL, et al. Recent experience with fungaemia: change in species distribution and azole resistance[J]. Scand J Infect Dis, 2009,41(4) :275-284.
  • 3Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection.. results from population-based surveillance, barcelona, Spain, from 2002 to 2003 [J]. J Clin Microbiol, 2005, 43 (4): 1829-1835.
  • 4Castagnola E, Machetti M, Bucci B, et al. Antifungal prophylaxis with azole derivatives [J]. Clin Microhiol Infect, 2004,10 (Suppl 1):86-95.
  • 5刘正印,盛瑞媛,李旭丽,李太生,王爱霞.院内真菌感染149例分析[J].中华医学杂志,2003,83(5):399-402. 被引量:153
  • 6Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance[J]. J Hosp Infect, 2002,50(4) : 243-260.
  • 7Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10. 5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion[J]. J Clin Microbiol, 2010,48(4) : 1366-1377.
  • 8Diekema DJ, Messer SA, Boyken LB, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods [J].J Clin Microbiol, 2009, 47 (10) : 3170-3177.
  • 9韩旭东,黄虑.深部真菌感染的临床和实验室诊断方案[J].上海医药,2004,25(10):441-443. 被引量:10
  • 10Medeiros EA, Lott TJ, Colombo AL, et al. Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil[J]. J Clin Microbiol, 2007,45(3): 942-947.

二级参考文献25

  • 1杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 2Pfaller MA, Jones RN, Messer SA, et al. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program . Diagn Microbiol Infect Dis,1998,31(1):327.
  • 3Rangel-Frausto S, Wiblin T, Blumberg HM, et al .Variation in rates of candida bloodstream infection in seven surgical ICUs and six neonatal ICUs . Clin Infect Dis,1999,29(2):253.
  • 4Bow EJ, Laverdiere M, Lussier N, et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer, 2002,94(12):3230.
  • 5Viudes A, Peman J, Canton E,et al.Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis,2002,,21(11):767.
  • 6Dean, David A. MD,Burchard, Kenneth W.MD.Fungal infection in surgical patients.American Journal of Surgery,1996,(5):374.
  • 7Shelhamer JH,Moderator MD,Gill VJ,et al. The laboratory evaluation of opportunistic pulmonary infections. Annals of Internal Medicine,1996,124(6): 585.
  • 8Gumbo T, Isada CM, Hall G, et al.Candida glabrata fungemia: Clinical features of 139 patients. Medicine (Baltimore) 1999,78(4): 220.
  • 9Chen, KY,Ko SC,Hsueh PR,et al. Pulmonary Fungal Infection: Emphasis on microbiological spectra, patient outcome, and prognostic factors.Chest,2001,120(1):177.
  • 10McGuire W, Clerihew L, Austin N .Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants .Cochrane Database Syst Rev, 2004,(3):CD00385

共引文献161

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部